Transcription factor Fra-1 induces cholangitis and liver fibrosis
Open Access
- 10 January 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 53 (4) , 1287-1297
Abstract
Chronic diseases of the biliary system are common and may cause fibrosis and eventually progression to liver cirrhosis. The aim was to define a new mouse model of a cholangiopathy leading to liver fibrosis in fra-1tg mice. Liver pathology of fra-1tg mice was analyzed in detail by histology and flow cytometry. Transcript levels of fibrosis-related genes and matrix metalloproteinase (MMP) activities were quantified and immunohistochemical analysis additionally applied. The role of the immune system in this model was analyzed by crossing fra-1tg mice with rag2 -/- mice. Furthermore, expression of Fra-1 in corresponding human liver diseases was investigated on transcription level and histologically. Fra-1tg mice spontaneously develop biliary fibrosis preceded by ductular proliferation and infiltration of inflammatory cells. Fra-1 protein is present in cholangiocytes and inflammatory cells within the liver. These findings were replicated in human biopsies of patients with advanced liver fibrosis. The inflammatory infiltrate showed a strong increase in activated T cells and decreased natural killer (NK), natural killer T cells (NKT), and B cells in fra-1tg mice as compared to wildtype mice. Moreover, fra-1tg mice develop biliary fibrosis with a time-dependent increase in hepatic collagen content and increase in relative messenger RNA (mRNA) expression of profibrotic genes. Attenuation but not complete prevention of collagen accumulation in liver was observed in the fra-1tg × rag2-/- mice. However, transplantation of fra-1tg bone marrow cells into wildtype mice could not induce disease. Conclusion: Fra-1tg mice spontaneously develop a progressive biliary disease. These mice are an attractive model for the investigation of cholangiopathies and their interaction with the immune system. (HEPATOLOGY 2011;)Keywords
This publication has 23 references indexed in Scilit:
- Gene expression profiles reflect sclerosing cholangitis activity inabcb4 (−/−)miceScandinavian Journal of Gastroenterology, 2009
- Cholangiocyte Injury and Ductopenic SyndromesSeminars in Liver Disease, 2007
- Molecular mechanisms of hepatic fibrogenesisJournal of Gastroenterology and Hepatology, 2007
- 24-norUrsodeoxycholic Acid Is Superior to Ursodeoxycholic Acid in the Treatment of Sclerosing Cholangitis in Mdr2 (Abcb4) Knockout MiceGastroenterology, 2006
- Inhibition of ALK5 as a New Approach to Treat Liver Fibrotic DiseasesDrug News & Perspectives, 2006
- FRA-1 expression level regulates proliferation and invasiveness of breast cancer cellsOncogene, 2004
- AP-1: a double-edged sword in tumorigenesisNature Reviews Cancer, 2003
- Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthOncogene, 2002
- Liver fibrosisSpringer Seminars in Immunopathology, 1999
- The immunobiology of bile and biliary epitheliumHepatology, 1999